# Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness

> **NCT06914583** · NA · RECRUITING · sponsor: **IBSA Farmaceutici Italia Srl** · enrollment: 500 (estimated)

## Conditions studied

- Facial Dryness
- Facial Dullness

## Interventions

- **DEVICE:** Sodium Hyaluronate

## Key facts

- **NCT ID:** NCT06914583
- **Lead sponsor:** IBSA Farmaceutici Italia Srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-19
- **Primary completion:** 2025-11
- **Final completion:** 2026-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914583, "Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06914583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*